Picture of Lunai Bioworks logo

LNAI — Lunai Bioworks News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Enochian Biosciences Announces FDA Acceptance Of Pre-IND Request For Potential Cure For Hepatitis B Virus Infection

July 12 (Reuters) - Enochian Biosciences Inc  ENOB.O :
    * ENOCHIAN BIOSCIENCES ANNOUNCES FDA ACCEPTANCE OF PRE-IND
REQUEST
 FOR POTENTIAL CURE FOR HEPATITIS B VIRUS INFECTION
    * ENOCHIAN BIOSCIENCES INC - FDA HAS ACCEPTED A PRE-IND
REQUEST
FOR A POTENTIAL CURE OF HEPATITIS B VIRUS (HBV) INFECTION
    * ENOCHIAN BIOSCIENCES INC - WRITTEN COMMENTS ARE EXPECTED
THIS
FALL.

Source text for Eikon:  ID:nGNXfFP8S 
Further company coverage:  ENOB.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Lunai Bioworks

See all news